Miscellaneous
Galafold (migalastat) was approved in August 2018 for the treatment of Fabry disease. Jerry Walter, a patient who has Fabry, and his nephrologist, Dr. Gerald Hladik, discuss how the drug works, and common concerns and questions patients have about the treatment.